Dimerix shoots higher on drug study update

SYDNEY: Shares in biotech firm Dimerix opened 6 per cent higher this morning, ... read more

Crescent stays ahead of curve with bid for Healthe Care hospitals

MELBOURNE: Private equity firm Crescent Capital has emerged in the final round of ... read more

Mesoblast braces for class action on drug disclosure

MELBOURNE: A law firm in Australia is preparing a fresh class action claim ... read more

Aegros set to move on to CSL’s plasma turf

MELBOURNE: It’s been a 30-plus year journey for small plasma fractionation biotech Aegros, ... read more